Le Lézard
Classified in: Ebola virus, Health, Covid-19 virus
Subject: PDT

Paerosol's New Disinfecting Technology Used in Florida Schools


CHARLESTON, S.C., July 31, 2021 /PRNewswire-PRWeb/ -- Marking almost one year since Corbett Preparatory School located in Tampa, Florida decided to implement Paerosol's Dry Spray Technologytm across its 17 buildings, the school has not reported a single case of COVID-19 nor the flu!

With schools throughout the world having a growing concern for the health and safety of their students and faculty following the COVID-19 pandemic, there has been a rise in demand for stronger cleaning supplies. With cleaning supplies such as multi-purpose cleaners and disinfectant wipes, they can be labor-intensive and leave surface areas easily missed. Paerosol's Dry Spray Technologytm has proven to disinfect both air-borne and surface-borne mold, bacteria, and viruses at a rate of up to 99.9999% efficacy1. Following Environmental Protection Agency (EPA) approval and having the Dry Spray Technologytm be used on all surfaces within the facility including classrooms, gyms, cafeterias, and locker rooms, the Corbett Preparatory School has reported 0 cases of COVID-19 and the flu, along with the average attendance record being the highest it's ever been.

"It's amazing to think that this technology has shown these types of results. I can't wait to see how this will do when more education institutions start to implement Paerosol."

About Paerosol - Paerosol is a platform which kills air and surface-borne mold, bacteria, and viruses at up to a 99.9999% rate of effectiveness. The Paerosol technology originated in the Department of Energy's Pacific Northwest National Laboratory ("PNNL") which is managed and operated by Battelle Memorial Institute. As part of the Federal Lab Commission's ("FLC") efforts to commercialize federally owned technology within the private sector, Paerosol LLC (founded by Steve Gareleck, CEO and Scott Alderson, President) obtained the exclusive licensing rights to this disinfecting technology directly from Department of Energy's Pacific Northwest National Laboratory. Paerosol's proprietary Dry Spray technology allows for Paerolyte's liquid disinfectant to get into all corners and crevices of any space it's placed in. Paerosol has been successfully tested by US & Foreign Government Agencies. The United States Defense Threat Reduction Agency successfully tested Paerosol against bio-agents including simulates of Anthrax and Ebola, common civilian and hospitals pathogens such as E Coli and Salmonella, antibiotic-resistant microbes, and viruses including H1N1 (swine flu), H5N1 (bird flu), MRSA, and the SARS-CoV-2 virus (COVID-19)2.

1. https://www.paerosol.com/wp-content/uploads/2020/03/PNNL-Paerosol-all-study-summary-from-BATTELLE-DoE.pdf, Pages 12 - 15
2. National Research Council. 2013. The Unique U.S.-Russian Relationship in Biological Science and Biotechnology: Recent Experience and Future Directions. Washington, DC: The National Academies Press. https://doi.org/10.17226/18277. 153.

Media Contact

Paerosol, Paerosol, 1-843-535-0500, [email protected]

SOURCE Paerosol


These press releases may also interest you

at 08:40
The "Global Cell Counting Market: Analysis By Product, By Application, By End-User, By Region Size, Trends and Forecast to 2029" report has been added to ResearchAndMarkets.com's offering. The global cell counting market was valued at US$9.98...

at 06:15
The "Global Immune Health Supplements Market - Outlook & Forecast 2023-2028" report has been added to  ResearchAndMarkets.com's offering. The global immune health supplements market was valued at $20.80 billion in 2022 and is expected to reach...

at 05:45
The Gross Law Firm issues the following notice to shareholders of Amplitude, Inc. . Shareholders who purchased shares of AMPL during...

at 05:45
The Gross Law Firm issues the following notice to shareholders of Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II ....

at 05:30
The "Syndromic Multiplex Panels Markets. Strategies and Trends. Forecasts by Syndrome (Respiratory, Sepsis, GI etc.) by Place, by Product and by Country. With Market Analysis and Executive Guides. 2024 to 2028" report has been added to...

at 05:00
The "Immunoassay Markets. Strategies and Trends. Forecasts by Application, Technology, Product, User and by Country. With Executive Guides, Customized Forecasting and Analysis. 2023 to 2027" report has been added to ResearchAndMarkets.com's offering....



News published on and distributed by: